Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The company faces challenges with declining revenue, increasing operating expenses, and a significant net loss. Despite some positive aspects like improved gross margins and a strengthened capital position, the risks related to strategic execution, market adoption, and competitive pressures overshadow these. The Q&A insights on milestones and hiring plans do not mitigate concerns about revenue variability and financial stability. Given these factors, the stock is likely to experience a negative reaction in the short term.
Revenue Revenue during our second quarter totaled approximately $61,000 compared to $183,000 in the prior year second quarter. This represents a significant decrease year-over-year, attributed to variability in revenue levels.
Gross Margin Gross margin for the second quarter increased to 43% from 32% in the second quarter of '24. The improvement is attributed to changes in revenue composition, though gross margin remains variable at current revenue levels.
Operating Expenses Operating expenses for the second quarter totaled $10.2 million compared to $5.3 million in the same quarter last year. The increase is primarily driven by employee-based expenses.
Net Loss The company reported a net loss attributable to common stockholders of $36 million for the second quarter or $0.26 per share compared to a net loss of $5 million in the second quarter of '24. The increase in net loss is primarily due to a $28 million non-cash loss on the value of the company's warrant-related derivative liability.
Cash and Equivalents Cash and equivalents increased by $270 million in the first 6 months of '25 to $349 million, bolstered by net proceeds of $188 million raised in the second quarter through an offering of common stock.
Total Assets As of June 30, '25, total assets stood at $426 million, up from $154 million in the year-end 2024. The increase is attributed to strengthened capital position and proceeds from financing activities.
Total Liabilities Total liabilities at the end of the second quarter were $30 million, which is a decrease of approximately $16 million compared to year-end 2024. This decrease is driven primarily by a non-cash mark-to-market adjustment for the QPhoton warrant derivative liability.
Stockholders' Equity Stockholders' equity rose to $396 million as of June 30, 2025, reflecting the company's strengthened capital position.
Quantum photonic vibrometer: Secured an order from Delft University of Technology for advanced work in nondestructive testing and structural health monitoring.
Commercial entangled photon source: Shipped to a leading research institution in South Korea for secure quantum communication experiments.
EmuCore reservoir computing system: Purchased by a major global automotive manufacturer for edge-based machine learning applications.
Quantum Cybersecurity Solution: First domestic commercial sale to a top 5 U.S. bank for secure data protection.
Quantum photonic chip facility: Grand opening of the facility in Tempe, Arizona, now fully operational and positioned to scale production for datacom, telecom, advanced sensing, and quantum computing.
Russell 3000 and Russell 2000 indexes inclusion: Increased visibility across institutional investors, reflecting recognition of QCI's progress.
Revenue and gross margin: Revenue for Q2 2025 was $61,000, with a gross margin increase to 43% from 32% in Q2 2024.
Capital position: Closed $200 million financing in June, ending Q2 with $349 million in cash and equivalents.
Operating expenses: Increased to $10.2 million in Q2 2025, primarily due to employee-based expenses.
Leadership appointments: New appointments include Interim CEO Yuping Huang, CFO Chris Roberts, COO Milan Begliarbekov, and CRO Pouya Dianat to support scaling the business.
Government partnerships: Awarded a $400,000 subcontract with NASA for quantum-based technology and a thin-film chip contract with the U.S. Department of Commerce.
Revenue Decline: Revenue for the second quarter of 2025 decreased significantly to $61,000 compared to $183,000 in the prior year, indicating challenges in generating consistent revenue growth.
Operating Expenses Increase: Operating expenses rose to $10.2 million in Q2 2025 from $5.3 million in Q2 2024, driven by employee-based expenses, which could strain profitability.
Net Loss Expansion: The company reported a net loss of $36 million in Q2 2025, a significant increase from $5 million in Q2 2024, primarily due to a $28 million non-cash loss related to warrant derivative liability.
Gross Margin Variability: Gross margin increased to 43% in Q2 2025 from 32% in Q2 2024, but remains highly variable due to low revenue levels, creating uncertainty in financial stability.
Strategic Execution Risks: The company is scaling its foundry and targeting significant revenue contributions in 12-18 months, but delays or execution challenges could impact financial performance.
Market Adoption Risks: While there are early signs of commercial adoption, the company’s technologies are still in the early stages of market penetration, posing risks to achieving broader adoption.
Competitive Pressures: The quantum computing and photonic chip industries are highly competitive, and QCI faces challenges in differentiating its offerings and maintaining a competitive edge.
Economic Uncertainties: Economic conditions could impact customer budgets and willingness to invest in quantum and photonic technologies, affecting QCI’s revenue growth.
Regulatory and Government Dependency: A significant portion of QCI’s revenue and contracts come from government institutions, making the company vulnerable to changes in government funding or priorities.
Revenue Growth: The company expects revenue from the quantum photonic chip foundry to grow significantly in the next 12 to 18 months as production scales.
Market Trends: The quantum technology industry is entering a period of rapid acceleration, with increasing awareness of its role in breakthroughs in climate science, defense, drug discovery, and secure communications. Additionally, there is strong momentum in domestic semiconductor and photonic factory opportunities.
Operational Efficiency: QCI's quantum architecture offers significant SWaP-C advantages, including room temperature operation, addressing energy consumption challenges in AI and digital infrastructure.
Strategic Investments: The company has a strengthened capital position with $349 million in cash and equivalents, enabling strategic investments in quantum machine programs and thin-film lithium niobate chip foundry initiatives.
The selected topic was not discussed during the call.
The company exhibits strong financial health with increased cash reserves and reduced liabilities. Strategic investments in partnerships and technology development are promising. The Q&A indicates optimism in quantum security and international expansion. The partnership with POET Technologies and increased shareholder equity are positive signals. However, lack of specific guidance on M&A targets and share count could cause slight uncertainty. Overall, the positive aspects outweigh the negatives, suggesting a positive stock price movement.
The company faces challenges with declining revenue, increasing operating expenses, and a significant net loss. Despite some positive aspects like improved gross margins and a strengthened capital position, the risks related to strategic execution, market adoption, and competitive pressures overshadow these. The Q&A insights on milestones and hiring plans do not mitigate concerns about revenue variability and financial stability. Given these factors, the stock is likely to experience a negative reaction in the short term.
The earnings call summary reveals strong financial performance, with significant net income and asset growth. Product development and market expansion efforts, like the NASA subcontract and sales to major institutions, are promising. However, the Q&A highlights some uncertainties, such as vague responses on capacity constraints and future foundry plans. Despite lower gross margins, the optimistic outlook, strategic partnerships, and robust financial position suggest a positive sentiment. The lack of specific shareholder return plans slightly tempers this, but overall, the company's trajectory appears positive for short-term stock movement.
The earnings call highlights a strong financial performance with a significant net income turnaround and increased cash reserves. The strategic partnership with NASA and sales to notable institutions bolster the positive outlook. Despite some operational and competitive risks, the overall sentiment is buoyed by strong financial health and promising market expansion plans. The Q&A reveals potential growth, albeit with vague timelines. The positive elements, such as net income and strategic partnerships, outweigh the risks, leading to a predicted stock price increase of 2% to 8%.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.